Temporary Suspension of In-Person Signature Requirement for Delivered Medications

Originally published April 27, 2020
Updated June 21, 2021

Effective July 1, 2021, the temporary suspension of in-person signatures for delivered medications is expired. More information can be found in the article titled “In-Person Signature Requirement for Delivered Medications,” that published on June 21, 2021.

Welfare and Institutions Code, Section 14043.341 requires providers that dispense controlled drugs, dangerous drugs or dangerous devices to a Medi-Cal beneficiary to maintain a record of the signature of the person receiving the drug or device. Pursuant to Executive Order N-55-20, effective immediately, the Department of Health Care Services (DHCS) will suspend these requirements and allow any form of delivery service tracking or electronically documented proof of delivery to suffice as proof of receipt of a drug or device by the Medi-Cal and Family Planning Access Care Treatment (PACT) beneficiary or authorized representative. This temporary policy change is instituted out of concern for the safety of all parties involved in the delivery of medications and/or devices to Medi-Cal and Family PACT beneficiaries during the response to coronavirus 2019 (COVID 19). The policy document is published on the DHCS COVID-19 Response page under the Providers and Partners heading as Pharmacy – In-Person Signature Rule Suspended for Delivered Medications. The policy is temporary and remains in effect until further notice.